David R. Holmes III

Statistics and Probability · 2000–2017

A researcher in the Science corpus: 20 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

• Statistics and Probability — 12 citations into it

Whom David R. Holmes III trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. John K. Kruschke

Who trusts David R. Holmes III overall

1. Vivek Y. Reddy
2. S. Doshi

Papers from David R. Holmes III's perspective

Ordered by how strongly the researchers David R. Holmes III trusts endorse each paper. Same corpus, a different order for every researcher.

1. Apixaban in patients with atrial fibrillation. (New England Journal of Medicine)
2. Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation (Annals of Internal Medicine)
3. Bayesian data analysis.
4. The Net Clinical Benefit of Warfarin Anticoagulation in Atrial Fibrillation (Annals of Internal Medicine)
5. Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study. (European Heart Journal)
6. Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial. (Journal of the American Medical Association (JAMA))
7. The third universal definition of myocardial infarction
8. Influence of Renal Function on the Effects of Early Revascularization in Non–ST-Elevation Myocardial Infarction: Data From the Swedish Web-System for Enhancement and Development of Evidence-Based… (Circulation)
9. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. (Journal of the American Medical Association (JAMA))
10. The safety of statins in clinical practice. (The Lancet)

Their papers

• 5-Year Outcomes After Left Atrial Appendage Closure: From the PREVAIL and PROTECT AF Trials. (2017) — 947 citations
• 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. (2014) — 1,053 citations
• Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial. (2014) — 1,676 citations
• 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. (2014) — 2,416 citations
• Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial. (2014) — 935 citations
• Percutaneous Left Atrial Appendage Closure for Stroke Prophylaxis in Patients With Atrial Fibrillation: 2.3-Year Follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients With Atrial Fibrillation) Trial (2013) — 625 citations
• Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II. (2013) — 786 citations
• Safety of Percutaneous Left Atrial Appendage Closure: Results From the Watchman Left Atrial Appendage System for Embolic Protection in Patients With AF (PROTECT AF) Clinical Trial and the Continued Access Registry (2011) — 889 citations
• 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, Society of Cardiovascular Anesthesi (2011) — 687 citations
• Outcomes in Patients With De Novo Left Main Disease Treated With Either Percutaneous Coronary Intervention Using Paclitaxel-Eluting Stents or Coronary Artery Bypass Graft Treatment in the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) Trial (2010) — 611 citations
• Assessment of the SYNTAX score in the Syntax study. (2009) — 606 citations
• Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. (2009) — 2,045 citations
• Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. (2009) — 4,081 citations
• Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemia. (2004) — 1,005 citations
• Randomized Study to Evaluate Sirolimus-Eluting Stents Implanted at Coronary Bifurcation Lesions (2004) — 803 citations
• Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. (2003) — 4,504 citations
• The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions. (2002) — 750 citations
• Incidence and Prognostic Importance of Acute Renal Failure After Percutaneous Coronary Intervention (2002) — 1,770 citations
• Localized intracoronary gamma-radiation therapy to inhibit the recurrence of restenosis after stenting. (2001) — 666 citations
• Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. (2000) — 2,156 citations